|
2025
|
P/S
|
Pharmaceutical preparations. |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of somatostatin-expressing neuroendo... |
|
|
P/S
|
Chemicals, namely, hyaluronic acid, hyaluronans and hylan polymers, and derivatives thereof, for ... |
|
|
Invention
|
Compositions and methods for treating and preventing macular degeneration.
Compositions and meth... |
|
|
Invention
|
Crystalline imidazo[4,5-b]pyridine compound, pharmaceutical compositions, and their use in treati... |
|
|
P/S
|
Advertising services to promote awareness of patients regarding multiple sclerosis. Providing onl... |
|
|
Invention
|
Lipid nanoparticles. Provided are lipid nanoparticles, compositions, and methods of making and us... |
|
|
Invention
|
Macrocyclic compounds, compositions, and methods of using thereof.
The present disclosure includ... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device includes a needle disposed at a distal e... |
|
|
Invention
|
Injector device. A medicament delivery device includes a needle, a needle cover, and a body. The ... |
|
|
Invention
|
Injector device. A medicament delivery device for reducing a force required to activate the devic... |
|
|
Invention
|
Treatment of hemophilia with fitusiran. The present disclosure provides methods for using fitusir... |
|
|
Invention
|
Artificial micrornas targeting snca. Provided herein are artificial microRNA (miRNA) molecules fo... |
|
|
Invention
|
Artificial micrornas targeting huntington's disease. Provided herein are artificial miRNA molecul... |
|
|
Invention
|
Methods for fus-based delivery of viral particles to the brain. Provided herein are methods to tr... |
|
|
Invention
|
Pegylated il-2 for suppressing adaptive immune response to gene therapy. The disclosure relates t... |
|
2024
|
Invention
|
Rabbit antibodies to human immunoglobulins g.
This disclosure anti-human IgG antibodies and anti... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device for injecting a medicament is described.... |
|
|
Invention
|
Crystalline form of an isoxazolidine derivative. The present disclosure relates to a compound of ... |
|
|
Invention
|
Hold assistance device for use with a medicament delivery device. A hold assistance device for us... |
|
|
Invention
|
Il-12 loss of potency muteins. The present invention provides pharmaceutical compositions compris... |
|
|
Invention
|
Artificial micrornas targeting tau.
Provided herein are artificial microRNA (miRNA) molecules fo... |
|
|
Invention
|
Artificial micrornas targeting tau. Provided herein are artificial microRNA (miRNA) molecules for... |
|
|
Invention
|
Multivariate spectral analysis and monitoring for biomanufacturing.
The disclosure features meth... |
|
|
Invention
|
Fluid transfer device. A fluid transfer device comprises a body comprising a first connecting por... |
|
|
Invention
|
Image-based motor function assessment. Methods and systems are provided to assess physical moveme... |
|
|
Invention
|
Methods for treating cd20-related disorders. Disclosed are methods of treating various disorders ... |
|
|
Invention
|
Methods for treating digitally-identified cd20-related disorders.
Disclosed are methods of treat... |
|
|
Invention
|
Vial adapter and injection kit for withdrawing a liquid medicament from an injection vial. A vial... |
|
|
Invention
|
Human pah expression cassette for treatment of pku by liver-directed gene replacement therapy.
P... |
|
|
Invention
|
Modified-igg antibodies that bind transforming growth factor-beta1 with high affinity, avidity an... |
|
|
P/S
|
Downloadable software in the nature of a mobile application for enabling users to enter, access, ... |
|
|
Invention
|
Oligosaccharides comprising an aminooxy group and conjugates thereof.
The invention provides met... |
|
|
Invention
|
Medicament delivery device. There is provided a medicament delivery device comprising: a main bod... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device has a needle, a body and a needle cover ... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device comprises: a needle for injecting a medi... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device includes: a body; a needle cover axially... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device comprises a housing, a needle, a needle ... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device has a needle for injecting medicament, a... |
|
|
Invention
|
Medicament delivery device. The present disclosure relates to a medicament delivery device compri... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disea... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device comprising a body, a needle, and an actu... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device includes a first component, a second com... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device includes an actuator including an actuat... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device includes a needle being axially moveable... |
|
|
Invention
|
Medicament delivery device. A medicament delivery device has an actuation member which is movable... |
|
|
Invention
|
Medicament delivery device.
A medicament delivery device includes a needle disposed at a distal ... |
|
2023
|
P/S
|
Pharmaceutical products for the prevention and treatment of immunological diseases; pharmaceutica... |
|
|
P/S
|
Pharmaceutical products for the prevention and treatment of immunological diseases, pharmaceutica... |
|
|
P/S
|
Pharmaceuticals for use in the treatment of lysosomal storage diseases |
|
|
P/S
|
Support services for patients and caregivers in the field of rare genetic diseases and disorders,... |
|
|
Invention
|
Methods for identifying and treating diseases.
Provided are methods for assessing aberrant glyco... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autosomal dominant polycystic kidney disease; ph... |
|
2022
|
Invention
|
Pyrazolopyrazine compounds as shp2 inhibitors.
Provided herein are compounds and pharmaceutical ... |
